Navigation Links
Denmark joins the Nordic EMBL Partnership for Molecular Medicine
Date:3/5/2013

Today, the Nordic EMBL Partnership for Molecular Medicine celebrates two important milestones: the renewal of the partnership agreement for an extended period of 10 years, and the expansion of the Nordic EMBL network with the official opening of the Danish Research Institute of Translational Neuroscience (DANDRITE) at Aarhus University, which will become its Danish node.

The Nordic EMBL Partnership for Molecular Medicine was initiated in 2007 between the University of Oslo, Ume University, University of Helsinki and EMBL. As a result, three nodes were established in Norway, Sweden and Finland, each of which complements the research expertise of the other partners and, working closely with EMBL, aims to rise to challenges in biomedicine and to foster industry collaborations. In the five years since the launch of the partnership, the network has emerged as a strategic player in the molecular understanding of disease mechanisms in Europe, its impact and success recognised with today's signing of a renewed partnership agreement for an extended period of 10 years.

The research alliance is further strengthened by the growth of the partnership through the creation and inauguration of a Danish node. Complementing the research profile of the three existing nodes, DANDRITE will focus on conducting state-of-the-art research in the field of neuroscience. "We're excited to welcome Denmark as the fourth partner in the Nordic EMBL Partnership for Molecular Medicine. In a competitive national process, Aarhus University was selected to host the Danish node. The decision was made on the basis of the university's scientific expertise in the neurosciences and its research environment, which offer an excellent base for building a world-class collaborative institute like DANDRITE," says Iain Mattaj, Director General of EMBL.

The establishment of the Danish node was made possible through the Lundbeck Foundation, one of the largest private contributors to natural science research in Denmark, which funds the new centre jointly with Aarhus University. "The partnership with EMBL has arisen from the independent research approach, and DANDRITE has high ambitions, plenty of funding, independence and excellent infrastructure. Our ambition is to be the first with the latest ideas, rather than having to stand on the shoulders of others," says Poul Nissen, Director of DANDRITE and Professor of Protein Biochemistry at Aarhus University.

DANDRITE joins the Institute for Molecular Medicine Finland (FIMM, University of Helsinki), Centre for Molecular Medicine Norway (NCMM, University of Oslo), the Laboratory for Molecular Infection Medicine Sweden (MIMS, Ume University) and EMBL. All nodes benefit from continuous scientific and administrative support from EMBL, as well as from adopting aspects of the EMBL operational model, such as international recruitment, staff-turnover and the external review system.


'/>"/>

Contact: Lena Raditsch
lena.raditsch@embl.de
49-062-213-878-125
European Molecular Biology Laboratory
Source:Eurekalert  

Related biology news :

1. Denmark can triple its biomass production and improve the environment
2. Warren Lammert Joins IntelliMedix Board of Advisors
3. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
4. Book shows evolution that joins human and environmental sciences
5. Brazil joins global initiative for biodiversity data access
6. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
7. Brazil joins international marine research effort
8. Steve Fisher joins American Health IT LLC as VP of Operations
9. Flavor and the new Nordic cuisine: BioMed Centrals new scientific journal Flavor is launched
10. New grants to innovation corps nodes further enhance public-private partnership
11. CHOP and BGI strengthen partnership with agreement on pediatric brain tumor collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Denmark joins the Nordic EMBL Partnership for Molecular Medicine
(Date:10/19/2019)... (PRWEB) , ... October 18, 2019 , ... ... share their research, new ideas, and experience the best their field has to ... relating to life-science projects in industry and research. , Micro- and Nanopositioning Stages ...
(Date:10/17/2019)... ... 2019 , ... LeadingBiotech , an exclusive event series ... NY/NJ CEO conference to be held on November 5, 2019 at ... event offers senior-level industry leaders a unique opportunity to collaborate, build partnerships and ...
(Date:10/10/2019)... SAN DIEGO (PRWEB) , ... October 09, 2019 ... ... their merger-acquisition of Nanosens Innovations, Inc., the creators of CRISPR-Chip™. Cardea first ... announcement of their Early Access Program for the Genome Sensor™. Built with CRISPR-Chip ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... 02, 2019 , ... eKare’s inSight® digital 3D imaging and wound measurement system ... East Midlands Academic Health Science Network (EMAHSN), the innovation arm of the NHS. The ... support to develop and deploy solutions to the most pressing challenges facing the NHS. ...
(Date:9/24/2019)... ... 24, 2019 , ... Drug resistance has been declared as one of the ... becoming one of the most serious concerns. Hong Kong cannot be spared from the ... (CA-MRSA), or a seven-fold of the figure in 2007 – the year the disease ...
(Date:9/22/2019)... ... September 20, 2019 , ... ... Brain-Derived Neurotrophic Factor (BDNF) testing in serum . BDNF plays a vital ... stimulates the growth and differentiation of new neurons in the brain involved in ...
(Date:9/17/2019)... ... September 16, 2019 , ... When a lot of ... that allow for the complete 3D characterization of tissues through the use of confocal ... an imaging, image analysis and advanced cell culture focused contract research organization and today ...
Breaking Biology Technology: